Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Purva Bali

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Frontiers in Genetics|May 30, 2013
MicroRNAs and Drug AddictionPurva Bali, Paul J Kenny
Dialogues in Clinical Neuroscience|January 18, 2020
Transcriptional mechanisms of drug addiction
Purva Bali, Paul J Kenny
Neuron|September 17, 2021
Gene splicing SETs the scene for cocaine addictionPurva Bali, Paul J Kenny
Epigenetics|May 19, 2011
Methylation, memory and addictionPurva Bali, Heh-In Im, Paul J Kenny
Nature Neuroscience|August 17, 2010
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212Heh-In Im, Jonathan A Hollander, Purva Bali, et al.
Gynecologic Oncology|April 16, 2003
Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cellsDavid Griffin, Sylvie Wittmann, Fei Guo, et al.
Cancer Research|November 25, 2003
Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cellsRamadevi Nimmanapalli, Purva Bali, Erica O'Bryan, et al.
Molecular Cancer Therapeutics|October 28, 2003
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BLianne Fuino, Purva Bali, Sylvie Wittmann, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Molecular Cancer Therapeutics|September 20, 2005
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824Liwei Chen, Songshu Meng, Hai Wang, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Genetics|May 30, 2013
MicroRNAs and Drug AddictionPurva Bali, Paul J Kenny
Dialogues in Clinical Neuroscience|January 18, 2020
Transcriptional mechanisms of drug addiction
Purva Bali, Paul J Kenny
Neuron|September 17, 2021
Gene splicing SETs the scene for cocaine addictionPurva Bali, Paul J Kenny
Epigenetics|May 19, 2011
Methylation, memory and addictionPurva Bali, Heh-In Im, Paul J Kenny
Nature Neuroscience|August 17, 2010
MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212Heh-In Im, Jonathan A Hollander, Purva Bali, et al.
Gynecologic Oncology|April 16, 2003
Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cellsDavid Griffin, Sylvie Wittmann, Fei Guo, et al.
Cancer Research|November 25, 2003
Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cellsRamadevi Nimmanapalli, Purva Bali, Erica O'Bryan, et al.
Molecular Cancer Therapeutics|October 28, 2003
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BLianne Fuino, Purva Bali, Sylvie Wittmann, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Molecular Cancer Therapeutics|September 20, 2005
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824Liwei Chen, Songshu Meng, Hai Wang, et al.
Pageof 3